| Financial Year |
March 31 2023 |
| Monetary Funds |
2,451,467,661.12 |
| Held-for-trading Financial Assets |
3,017,384,897.26 |
| Notes Receivable |
2,091,840.00 |
| Accounts Receivable |
1,040,916,585.92 |
| Advances to Suppliers |
47,978,842.49 |
| Other Receivables |
101,024,309.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
346,723,423.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,209,748.26 |
| Total Current Assets |
7,049,797,308.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
291,316,964.59 |
| Investment Properties |
-- |
| Fixed Assetes |
502,758,455.30 |
| Under-construction Projects |
290,217,240.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,076,547.64 |
| R&D expenses |
7,758,464.23 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
46,941,737.41 |
| Deferred Income Tax Assets |
67,592,729.13 |
| Other Non-Current Assets |
10,620,394.50 |
| Sub-Total of Non-Current Assets |
1,677,257,425.56 |
| Total Assets |
8,727,054,733.64 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,400,000.00 |
| Accounts Payable |
572,527,253.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
199,585,428.66 |
| Taxes Payable |
100,774,241.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
154,990,486.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,377,726.02 |
| Other Current Liabilities |
992,117.79 |
| Sub-Total of Current Liabilities |
1,087,834,786.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,781,536.29 |
| Deferred Income Tax Liabilities |
22,605,869.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
64,976,658.80 |
| Total Liabilities |
1,152,811,445.70 |
| Paid-In Capital(Or Share Stock) |
588,459,803.00 |
| Capital Surplus |
1,918,224,370.13 |
| Surplus Reserve |
294,229,901.50 |
| LESS:Treasury Stock |
392,601,314.89 |
| Undistributed Profits |
5,136,266,502.91 |
| Minority Stockholder's Interest |
12,132,645.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,562,110,642.18 |
| Owner's Equity（Stockholder's Equity） |
7,574,243,287.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,727,054,733.64 |
